The use of Gd DTPA as a perfusion agent and marker of blood-brain barrier disruption.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Magnetic Resonance Imaging

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0730-725X(85)90008-6PMID 3923292
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intravascular contrast agents suitable for magnetic resonance imaging.

  1984cited by this paper
• Intravenous chelated gadolinium as a contrast agent in NMR imaging of cerebral tumours.

  1984cited by this paper
• Contrast enhancement of magnetic resonance images by chromium EDTA: an experimental study.

  1984cited by this paper
• Paramagnetic contrast agents in magnetic resonance imaging: research at Vanderbilt University.

  1984cited by this paper
• [Human testing of the nuclear spin tomographic contrast medium gadolinium-DTPA. Tolerance, contrast affect and the 1st clinical results].

  1984cited by this paper
• Prüfung des kernspintomographischen Kontrastmittels Gadolinium-DTPA am Menschen

  1984cited by this paper
• Nuclear magnetic resonance imaging of the cardiovascular system: normal and pathologic findings.

  1983cited by this paper
• Work in progress: nuclear magnetic resonance study of a paramagnetic nitroxide contrast agent for enhancement of renal structures in experimental animals.

  1983cited by this paper
• Paramagnetic agents for contrast-enhanced NMR imaging: a review.

  1983cited by this paper
• Work in progress: potential oral and intravenous paramagnetic NMR contrast agents.

  1983cited by this paper
• Clinical NMR imaging of the brain: 140 cases.

  1982cited by this paper
• Radiographic quantitation of reversible blood-brain barrier disruption in vivo.

  1982cited by this paper
• Preliminary experimental results in humans and animals with a superconducting, whole-body, nuclear magnetic resonance scanner.

  1982cited by this paper
• Experimental brain abscess evolution: computed tomographic and neuropathologic correlation.

  1979cited by this paper
• Kernmagnetische Relaxation und Korrelation in Zwei-Spin-Systemen

  1964cited by this paper

• 18F-Fluciclovine PET enables accurate and safe resection of malignant brain tumors: illustrative cases

  2025cites this paper
• Material-based neuroimaging and biomarker detection for central nervous system disorder

  2025cites this paper
• Amide proton transfer weighted MRI measurements yield consistent and repeatable results in patients with gliomas: a prospective test-retest study

  2024cites this paper
• Fluorescence real-time kinetics of protoporphyrin IX after 5-ALA administration in low-grade glioma.

  2021cites this paper
• Study on Establishing Reference Safe Concentrations of MRI Contrast Agents for Optimized Images: Paramagnetic Gd-DTPA-BMEA and Superparamagnetic Ferucarbotran

  2021cites this paper
• Hyperpolarized 129Xe Time-of-Flight MR Imaging of Perfusion and Brain Function

  2020cites this paper
• The value of arterial spin labelling in adults glioma grading: systematic review and meta-analysis

  2019cites this paper
• Diagnostic value of alternative techniques to gadolinium-based contrast agents in MR neuroimaging—a comprehensive overview

  2019cites this paper
• Overview and Critical Appraisal of Arterial Spin Labelling Technique in Brain Perfusion Imaging

  2018cites this paper
• Transcranial Acoustic Imaging for Guiding Cavitation-Mediated Ultrasonic Brain Therapy

  2018influential citation
• Towards clinically translatable in vivo nanodiagnostics.

  2017cites this paper
• Cerebrovascular integrity maintenance and inflammation in atherosclerosis animal models

  2016cites this paper
• Manganese-Enhanced Magnetic Resonance Imaging as a Diagnostic and Dispositional Tool after Mild-Moderate Blast Traumatic Brain Injury

  2016cites this paper
• Characterization of passive permeability at the blood–tumor barrier in five preclinical models of brain metastases of breast cancer

  2016cites this paper
• Metabolic guided vascular analysis of brain tumors using MR/PET

  2016cites this paper
• Drug and gene delivery across the blood-brain barrier with focused ultrasound.

  2015cites this paper
• Tumor growth suppression by gadolinium-neutron capture therapy using gadolinium-entrapped liposome as gadolinium delivery agent.

  2013cites this paper
• Enhancement in a brain glioma model: A comparison of half‐dose gadobenate dimeglumine versus full‐dose gadopentetate dimeglumine at 1.5 and 3 T

  2013cites this paper
• Targeted radiotherapy for cancer

  2012cites this paper
• Proton MR spectroscopy in predicting the increase of perfusion MR imaging for WHO grade II gliomas

  2012cites this paper
• [Multimodal magnetic resonance imaging of brain tumors].

  2011cites this paper
• The Developmental History of the Gadolinium Chelates as Intravenous Contrast Media for Magnetic Resonance

  2011cites this paper
• Quantitative and Noninvasive Assessment of Prenatal X-Ray-Induced CNS Abnormalities Using Magnetic Resonance Imaging

  2011cites this paper
• Evaluation of a Fibrin-Binding Gadolinium Chelate Peptide Tetramer in a Brain Glioma Model

  2011cites this paper
• Evaluation of Gadodiamide Versus Gadobutrol for Contrast-Enhanced MR Imaging in a Rat Brain Glioma Model at 1.5 and 3 T

  2010cites this paper
• In vivo visualization of reactive gliosis using manganese-enhanced magnetic resonance imaging

  2010cites this paper
• Vergleich der experimentellen Kontrastmittel P792 und P846 gegenüber Gd-DOTA hinsichtlich Kontrastmittelanreicherung und Kontrast-zu-Rausch-Verhältnis bei experimentell erzeugten Hirngliomen in Ratten mittels MRT bei 3 T.

  2010cites this paper
• In vivo Assessment of Macrophage CNS Infiltration during Disruption of the Blood–Brain Barrier with Focused Ultrasound: A Magnetic Resonance Imaging Study

  2010cites this paper
• Brain Tumor Enhancement in Magnetic Resonance Imaging: Dependency on the Level of Protein Binding of Applied Contrast Agents

  2009cites this paper
• Magnetic resonance imaging enhanced by superparamagnetic iron oxide particles: Usefulness for distinguishing between focused ultrasound‐induced blood–brain barrier disruption and brain hemorrhage

  2009cites this paper
• Comparative Evaluation of Lesion Enhancement Using 1 M Gadobutrol vs. 2 Conventional Gadolinium Chelates, All at a Dose of 0.1 mmol/kg, in a Rat Brain Tumor Model at 3 T

  2009cites this paper
• Brain Tumor Enhancement in Magnetic Resonance Imaging at 3 Tesla: Intraindividual Comparison of Two High Relaxivity Macromolecular Contrast Media With a Standard Extracellular Gd-Chelate in a Rat Brain Tumor Model

  2009cites this paper
• Molecular and functional imaging in radiation oncology.

  2008cites this paper
• A role for leukocyte-endothelial adhesion mechanisms in epilepsy

  2008cites this paper
• Gadolinium(III)-based blood-pool contrast agents for magnetic resonance imaging: status and clinical potential

  2007cites this paper
• Role of Perfusion CT in Glioma Grading and Comparison with Conventional MR Imaging Features

  2007cites this paper
• Arterial Spin-Labeling and MR Spectroscopy in the Differentiation of Gliomas

  2007cites this paper
• The Efficacy of Gadobenate Dimeglumine (Gd-BOPTA) at 3 Tesla in Brain Magnetic Resonance Imaging: Comparison to 1.5 Tesla and a Standard Gadolinium Chelate Using a Rat Brain Tumor Model

  2006cites this paper
• Gadolinium diethylenetriaminopentaacetic acid-loaded chitosan microspheres for gadolinium neutron-capture therapy.

  2006cites this paper
• Brain Tumor Enhancement in Magnetic Resonance Imaging: Comparison of Signal-to-Noise Ratio (SNR) and Contrast-to-Noise Ratio (CNR) at 1.5 Versus 3 Tesla

  2005cites this paper
• Gadolinium-Enhanced Magnetic Resonance Imaging in Multiple Infarction

  2005cites this paper
• Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging.

  2002cites this paper
• Gadolinium in human glioblastoma cells for gadolinium neutron capture therapy.

  2001influential citation
• Sulcal hyperintensity on fluid-attenuated inversion recovery mr images in patients without apparent cerebrospinal fluid abnormality.

  2001cites this paper
• Dietary antioxidants and assessment of oxidative stress.

  2000cites this paper
• Interleukin-1 b-Induced Changes in Blood – Brain Barrier Permeability , Apparent Diffusion Coefficient , and Cerebral Blood Volume in the Rat Brain : A Magnetic Resonance Study

  2000cites this paper
• Neuroimaging contrast agents in ophthalmology.

  2000cites this paper
• Interleukin-1β-Induced Changes in Blood–Brain Barrier Permeability, Apparent Diffusion Coefficient, and Cerebral Blood Volume in the Rat Brain: A Magnetic Resonance Study

  2000cites this paper
• Improved contrast agent bolus tracking using T1 FARM

  1999cites this paper
• Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation

  1998cites this paper
• Rationale for the use of contrast media in MR imaging.

  1997cites this paper
• MRI lesion activity in relapsing-remitting patients with multiple sclerosis

  1996cites this paper
• Experimental Cerebral Venous Thrombosis: Evaluation Using Magnetic Resonance Imaging

  1996cites this paper
• Comparative in vivo and pathological analysis of the blood‐brain barrier in mouse telencephalic transplants

  1996cites this paper
• Magnetic resonance imaging-monitored acute blood-brain barrier changes in experimental traumatic brain injury.

  1996cites this paper
• Neurotoxicity of gadolinium contrast agents for magnetic resonance imaging in rats with osmotically disrupted blood-brain barrier.

  1996cites this paper
• Assessment of myocardial perfusion using contrast-enhanced MR imaging: Current status and future developments

  1995cites this paper
• Contrast enhancement in primary tumors of the brain and spinal cord.

  1994cites this paper
• Delineation of gliomas with various doses of MR contrast material.

  1994cites this paper
• Magnetite as a potent contrast-enhancing agent in magnetic resonance imaging to visualize blood-brain barrier disruption.

  1993cites this paper
• Temporal Bone, Middle Skull Base, and Cerebellopontine Angle

  1992cites this paper
• 脳卒中易発症ラット(SHRSP)の脳血管障害発症過程解明へのMRI利用の試み

  1992cites this paper
• An evaluation of the integrity of the blood‐testis barrier by magnetic resonance imaging

  1991cites this paper
• Blood-retinal barrier breakdown investigated by real-time magnetic resonance imaging after gadolinium-diethylenetriaminepentaacetic acid injection.

  1991cites this paper
• Effect of short-term ethanol feeding on rat testes as assessed by 31P NMR spectroscopy, 1H NMR imaging, and biochemical methods.

  1991cites this paper
• Magnetic resonance imaging of rat brain following in vivo disruption of the cerebral vasculature.

  1991cites this paper
• Cerebral necrosis simulating an intraparenchymal tumor.

  1990cites this paper
• Gadolinium-DTPA-enhanced and digitally subtracted magnetic resonance imaging of estrogen-induced pituitary lesions in rats: correlation with pituitary anatomy.

  1990cites this paper
• Functional cerebral imaging by susceptibility‐contrast NMR

  1990cites this paper
• Perfusion imaging with NMR contrast agents

  1990cites this paper
• Magnetic Resonance Imaging of Carcinoma of the Urinary Bladder

  1990cites this paper
• Quantitation of blood‐brain barrier defect by magnetic resonance imaging and gadolinium‐DTPA in patients with multiple sclerosis and brain tumors

  1990cites this paper
• A magnetic resonance imaging contrast agent differentiates between the vascular properties of fetal striatal tissue transplants and gliomas in rat brain in vivo.

  1989cites this paper
• Platelet levels of glutamate and aspartate in normal subjects.

  1989cites this paper
• Gadolinium-enhanced magnetic resonance imaging in multiple infarction.

  1989cites this paper
• Gd-enhanced MR imaging of acute and chronic experimental demyelinating lesions.

  1988cites this paper
• Dynamic imaging with lanthanide chelates in normal brain: Contrast due to magnetic susceptibility effects

  1988cites this paper
• MR contrast enhancement of intracranial lesions with Gd-DTPA.

  1988cites this paper
• Contrast Agents in MRI: Clinical Applications of Gadolinium-DTPA in the Central Nervous System

  1988cites this paper
• Monoclonal Antibody Labeling with Indium-111 and Gadolinium via DTPA Chelation on Selective and Nonselective Sites of the Antibody

  1988cites this paper
• Paramagnetic enhanced proton magnetic resonance measurement in rats: correlates with renal function.

  1988cites this paper
• Paramagnetic contrast enhancement at 0.02 T: An experimental study using Gd‐DOTA in normal and hydronephrotic kidneys

  1988cites this paper
• Comparison of CT and MRI brain tumor imaging using a canine glioma model.

  1988cites this paper
• Dyke award. Gd-DTPA-enhanced MR imaging of experimental bacterial meningitis: evaluation and comparison with CT.

  1988cites this paper
• Magnetic resonance brain tumor imaging in canine glioma

  1987cites this paper
• Reversed-phase high-performance liquid chromatographic determinationof gadolinium-diethylenetriaminepentaacetic acid complex

  1986cites this paper
• experimental demyelinating lesions. Gd-enhanced MR imaging of acute and chronic

  year unknowncites this paper
• intraparenchymal tumor. Cerebral necrosis simulating an

  year unknowncites this paper